Piramal Pharma (NSE:PPLPHARMA) Other Net Income (Loss) : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Other Net Income (Loss)?

Piramal Pharma's Other Net Income (Loss) for the three months ended in Mar. 2025 was ₹0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Piramal Pharma's quarterly Other Net Income (Loss) increased from Sep. 2024 (₹-0 Mil) to Dec. 2024 (₹0 Mil) but then declined from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil).

Piramal Pharma's annual Other Net Income (Loss) declined from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹-0 Mil) but then increased from Mar. 2024 (₹-0 Mil) to Mar. 2025 (₹0 Mil).

Piramal Pharma Other Net Income (Loss) Historical Data

The historical data trend for Piramal Pharma's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Other Net Income (Loss) Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Other Net Income (Loss)

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial											-	-	-	-	-

Piramal Pharma Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Piramal Pharma Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

543635:India

Address

Kamani Junction, LBS Marg, Ground Floor, Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramalpharma.com

Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.

Piramal Pharma Headlines

No Headlines